## Abstract ## BACKGROUND The goal of the current study was to retrospectively assess the prognostic impact of __TP53__ mutation status and P53 expression/accumulation on longβterm outcome for adult patients with supratentorial World Health Organization (WHO) Grade II astrocytoma or oligoastrocyto
Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas : A new pattern of prognostic factors
β Scribed by Friedrich W. Kreth; Michael Faist; Reinhard Rossner; Benedikt Volk; Christoph B. Ostertag
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 248 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Background:
Prognostic factors for adult patients with supratentorial world health organization (who) grade 2 astrocytomas and poorly defined.
Methods:
The prognostic importance of pretreatment patient- and tumor-related factors was analyzed retrospectively in 197 adult patients with supratentorial astrocytomas (n = 153) or oligoastrocytomas (n = 44) using the multivariate cox proportional hazards model. endpoints were death and date of malignant transformation. all patients were treated similarly between 1979 and 1992 with iodine-125 implants as the primary treatment.
Results:
A new prognostic pattern was detected. unfavorable prognostic factors with regard to survival were 1) a tumor volume > or = 20 ml; 2) a performance status < or = 80; and 3) age > or = 40 years for the female subpopulation. midline shift (another important tumor-related factor after univariate analysis) was highly correlated with tumor volume and therefore not included in the multivariate model. risk factors of malignant transformation were 1) a tumor volume > or = 20 ml; 2) an enhancement in the computed tomography scan; and 3) age > or = 40 years for the female subpopulation. prognostic factors created subsets of patients with 5-year survival rates ranging from as low as 5% to as high as 79%.
Conclusions:
Any treatment decision or evaluation of treatment efficacy should take into account the strong influence of both patient- and tumor-related factors. any further study design should consider the detected interaction between gender and age and the importance of tumor volume.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Detailed longβterm outcome data are not available for adult patients with World Health Organization (WHO) Grade 2 astrocytoma or oligoastrocytoma. ## METHODS A previously published shortβterm data set of 239 adult patients with circumscribed de novo supratentorial astro
## BACKGROUND. Prognostic factors in oligodendrogliomas are an area of controversy in neuropathology. Although grading and the study of some morphologic variables may be of value as prognostic parameters, the variability of postoperative disease free survival in patients with World Health Organizat